Mitchell A A, Goldman P, Shapiro S, Slone D
Am J Epidemiol. 1979 Aug;110(2):196-204. doi: 10.1093/oxfordjournals.aje.a112804.
An intensive drug surveillance program has been developed to study the clinical effects of drugs in hospitalized children. This program collects information on drug exposures and the occurrence of adverse clinical events. The 1669 children monitored to date received an average of 7.6 drugs during an average hospital stay of 8.4 days. A group of specified adverse clinical events, whether or not drug attributed, occurred in 45.7% of the patients; drug-attributed events (adverse drug reactions) occurred in 16.8%. Both drug use and reported adverse reactions tended to increase with age, except that newborns received many drugs but had the lowest reported adverse reaction rates. Newborns, however, had the highest rate of adverse events not attributed to drugs, suggesting that perhaps some of these latter events include presently unrecognized adverse drug reactions.
已开展一项强化药物监测项目,以研究药物对住院儿童的临床影响。该项目收集有关药物暴露情况及不良临床事件发生情况的信息。迄今为止监测的1669名儿童在平均8.4天的住院期间平均接受了7.6种药物治疗。一组特定的不良临床事件,无论是否归因于药物,在45.7%的患者中发生;药物归因事件(药物不良反应)发生在16.8%的患者中。药物使用和报告的不良反应均倾向于随年龄增加而增多,但新生儿接受的药物很多,但其报告的不良反应发生率最低。然而,新生儿非药物归因的不良事件发生率最高,这表明这些后期事件中可能有些包括目前未被识别的药物不良反应。